Web advisories aid physicians

Monitoring and rapidly introducing new developments into everyday practice is an increasingly difficult task for many doctors. Additionally, patients are more informed due to media medical reports, which raise their expectations that doctors can offer a quick, reliable interpretation of the latest medical data.

Our knowledge of the human body, possible predispositions to illness as well as...
Our knowledge of the human body, possible predispositions to illness as well as therapies, is constantly increasing. It is our duty as the world leader in diagnostics to collate this knowledge and deduce therapy recommendations from it, for the benefit of doctors and patients.” Heino von Prondzynski, Roche Diagnostics Head

Following most laboratory diagnostic tests, a doctor receives a report containing various measurements, which he/she uses to choose therapies. This offers diagnostics companies the potential to produce information to assist in the decision-making. Thus, in addition to developing increasingly sensitive diagnostic techniques, information technology (IT) will take a more central role in a firm’s business operations. This metamorphosis has already begun.

Heino von Prondzynski, Head of Roche Diagnostics, said: ‘Our knowledge of the human body, possible predisposition to illnesses, as well as therapies, is constantly increasing.  As the world leader in diagnostics, it is our duty to collate this knowledge and deduce therapy recommendations from it to benefit doctors and their patients.’ Roche Diagnostics’ range of ‘Actionable Health Information’ services does just that, as in the case of calculating the risks of late-occurring diabetic complications and costs of treatment. Roche’s Mellibase system regularly supplies prognoses to doctor and patient, on paper or electronically, for use in doctor-patient discussions and to help diabetics adapt their lifestyles accordingly.

The company’s RealFlu also helps diagnose influenza and encourages patients with flu-like symptoms to seek medical advice quickly. From October to April, the website www.mellibase.de provides information about influenza outbreaks in individual German states, and doctors who see influenza developing in their regions can raise diagnosis accuracy up to 80%.

Rapid IT development accelerates the transition from simple data management to a decision-making tool. ‘Actionable Health Information’ systems enable more effective treatments as well as improved allocation of resources. In future, this will contribute to a healthcare strategy that integrates costs, quality of life and medical quality, and optimise their interaction for the benefit of all.

Dr Burkhard Ziebolz, Roche Diagnostics

01.07.2003

Read all latest stories

Related articles

Photo

Image analysis integration

Roche opens access to digital pathology tools

Roche announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche’s uPath…

Photo

Automation

Proven Practices for Lab Automation Success

Cost constraints, higher workloads, and a shortage of qualified staff are three distinct market trends driving demand for greater efficiency in the laboratory. The goals of automation are to make…

Photo

Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche

Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's…

Related products

Fujifilm Wako – Autokit Total Ketone Bodies Assay

Clinical Chemistry

Fujifilm Wako – Autokit Total Ketone Bodies Assay

FUJIFILM Wako Chemicals Europe GmbH
FUJIFILM Wako - Toxinometer MT-6500

Identification/Susceptibility

FUJIFILM Wako - Toxinometer MT-6500

FUJIFILM Wako Chemicals Europe GmbH
Lifotronic - FA-160 Immunofluorescence Analyzer

Other

Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Alsachim, a Shimadzu group company – Dosinaco

Clinical Chemistry

Alsachim, a Shimadzu group company – Dosinaco

Alsachim, a Shimadzu Group Company
Analyticon Biotechnologies AG - Urilyzer 100 Pro

Urinalysis

Analyticon Biotechnologies AG - Urilyzer 100 Pro

Analyticon Biotechnologies AG
Subscribe to Newsletter